Atlas Trials

Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology

Clinical trial NCT02207179 · UNKNOWN

Trial details

NCT number
NCT02207179
Sponsor
LumaMed
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2014-01-01
Primary completion
2015-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.